Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

March-in rights explained

Maybe... kind of... It’s all very confusing actually

- PMLiVE

LEO shares positive results for delgocitinib cream in head-to-head chronic hand eczema study

Hand eczema is the most common skin disorder of the hands and one of the most common eczemas

- PMLiVE

Johnson & Johnson agrees $700m settlement to resolve talcum powder investigations

The deal would resolve US states’ probes into the marketing of its talcum products

- PMLiVE

Incisionless device to transform diabetes, liver disease and severe obesity treatment

ForePass replicates common invasive metabolic surgeries without making any incisions

- PMLiVE

New framework establishes two tests for use in clinical trials for Parkinson’s

The neurological condition currently affects around 145,000 people in the UK

- PMLiVE

Study shows blood test could be as accurate as lumbar punctures for detecting Alzheimer’s

ALZpath successfully detected levels of a form of the hallmark tau protein in the blood

- PMLiVE

Charting a course for ongoing omnichannel excellence

Successful customer engagement will require pharma to maintain a rigid focus throughout the journey

How_Do_We_Mentor_Excellence

Inside Mednet’s Writing Academy: How do you mentor excellence?

Medical Writer, Tayyibah Ali looks at how we mentor excellence within our team

Mednet

We are EatMoreFruit

Welcome to EatMoreFruit - We are a London-based top 10 independent healthcare communications agency. PR, digital, creative & commercial strategies for innovators in health, pharma and wellbeing.

EatMoreFruit

- PMLiVE

Sanofi expands rare disease pipeline with $2.2bn Inhibrx acquisition

The deal includes a mid-stage candidate for alpha-1 antitrypsin deficiency

- PMLiVE

AstraZeneca’s Imfinzi combination shows promise in phase 3 liver cancer study

Hepatocellular carcinoma accounts for about 75% of all primary liver cancers in adults

- PMLiVE

Study finds vaccination against COVID-19 reduces long COVID symptoms

The results could help inform public health strategies and vaccination campaigns

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links